Tuesday, 31 May 2022

Cuba lifts mask mandate as vaccination rate soars and deaths plummet

Cuba lifts mask mandate as vaccination rate soars and deaths plummet

Cuba on Tuesday lifted a mask mandate in place for two years following a successful vaccination drive that health officials say has contributed to a sharp drop in cases and nearly three weeks without a single death from COVID-19.

What to know about COVID vaccines for small children

Advisers to the U.S. Food and Drug Administration are due to meet in June to decide on whether to recommend authorizing Moderna Inc's vaccine for children below 6 years old, and Pfizer Inc and BioNTech SE's COVID-19 vaccine for children below 5 years old.

After two months, a scarred Shanghai's COVID-19 lockdown ends

Following two months of frustration, despair and economic loss, Shanghai's draconian COVID-19 lockdown ended at midnight on Wednesday morning, prompting celebrations tempered with fear that an outbreak could return.

Global baby formula makers send products to restock U.S. shelves

Global companies that make baby formula are bringing products into the United States after the country's health regulator relaxed its import policy to address a nationwide shortage partly triggered by Abbott Laboratories' manufacturing plant in Michigan recalling some products in February.

Norway reports its first case of monkeypox

Norway has identified its first case of monkeypox, the Institute of Public Health (FHI) said on Tuesday.

Hungary reports first case of monkeypox

Hungary has confirmed its first case of monkeypox, Surgeon General Cecilia Muller told state news agency MTI on Tuesday.

WHO aims to contain monkeypox outbreak by minimizing human transmission

It is not clear yet whether the spread of monkeypox can be contained completely, the World Health Organization said on Tuesday, adding that its goal was to contain the outbreak by stopping human-to-human transmission to the maximum extent possible.

What you need to know about the coronavirus right now

Here's what you need to know about the pandemic right now:

U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.

Swissmedic weighing new COVID booster recommendation for children

Swiss drugs regulator Swissmedic said on Tuesday it is reviewing an application from pharmaceutical company Pfizer for a new dosage recommendation for a COVID-19 booster shot for children.

Related Videos

Monkeypox can be contained if we act now: WHO

N.Korea reports more deaths amid COVID lockdown

After 65 days, American leaves China's lockdown